@article{scailteux:hal-02959030,
TITLE = {Overall survival among chemotherapy-na{\"i}ve castration-resistant prostate cancer patients under abiraterone versus enzalutamide: a direct comparison based on a 2014-2018 French population study (the SPEAR cohort)},
AUTHOR = {Scailteux, Lucie-Marie and Campillo-Gimenez, Boris and Kerbrat, Sandrine and Despas, Fabien and Mathieu, Romain and Vincendeau, S{\'e}bastien and Balusson, Fr{\'e}d{\'e}ric and Happe, Andr{\'e} and Nowak, Emmanuel and Oger, Emmanuel},
URL = {https://hal.science/hal-02959030},
JOURNAL = {American Journal of Epidemiology},
PUBLISHER = {Oxford University Press (OUP)},
VOLUME = {190},
NUMBER = {3},
PAGES = {413-422},
YEAR = {2021},
MONTH = Feb, DOI = {10.1093/aje/kwaa190},
KEYWORDS = {SNDS ; abiraterone ; enzalutamide ; metastatic castration-resistant prostate cancer ; overall survival ; population-based study},
PDF = {https://hal.science/hal-02959030/file/Scailteux_et_al_Overall_survival_among_chemotherapy_accepted.pdf},
HAL_ID = {hal-02959030},
HAL_VERSION = {v1},
}